Clinical Research in Cardiology Template
Write in a clean editor, then format for Clinical Research in Cardiology in one click — DocuGuru applies the official Springer Nature template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Research in Cardiology format
Clinical Research in Cardiology is a peer-reviewed journal published by Springer Nature, covering Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, Atrial Fibrillation Management and Outcomes.
| Publisher | Springer Nature |
|---|---|
| Reference style | Numbered (Springer Basic) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C (2023) A representative article title. Clinical Research in Cardiology 12:45–58
Formats any DOI in Clinical Research in Cardiology style. No sign-up. |
| Publishes research in | Cardiac Valve Diseases and Treatments Cardiovascular Function and Risk Factors Atrial Fibrillation Management and Outcomes Cardiac Imaging and Diagnostics Acute Myocardial Infarction Research |
| ISSN | 1861-0684 |
| Citation impact (2-yr) | 2.45 |
| h-index | 95 |
| i10-index | 1,798 |
| Total citations | 73,991 |
| Article processing charge | $3,990 |
| Top institutions publishing here | German Centre for Cardiovascular Research |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Research in Cardiology per year
Citation impact of Clinical Research in Cardiology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Research in Cardiology
Electronic health records (EHRs) provide opportunities to enhance patient care, embed performance measures in clinical practice, and facilitate clinical research. Concerns have been raised about the increasing recruitment challenges in trials, burdensome and obtrusive data collection, and uncertain generalizability of the results. Leveraging electronic health records to counterbalance these trends is an area of intense…
Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in Western countries and affects approximately 25% of the adult population. Since NAFLD is frequently associated with further metabolic comorbidities such as obesity, type 2 diabetes mellitus, or dyslipidemia, it is generally considered as the hepatic manifestation of the metabolic syndrome. In addition…
AIMS: Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF). Galectin-3 is a recently developed biomarker associated with fibrosis and inflammation, and it may play a role in cardiac remodeling in HF. We determined its prognostic value in patients with chronic HF. METHODS AND RESULTS: Patients with chronic HF…